High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial-Reference-Cited by-全球学者库

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

Published:2017-04-01 Issue:6 Volume:7 Page:586-595
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Massard Christophe,Michiels Stefan,Ferté Charles,Le Deley Marie-Cécile,Lacroix Ludovic,Hollebecque Antoine,Verlingue Loic,Ileana Ecaterina,Rosellini Silvia,Ammari Samy,Ngo-Camus Maud,Bahleda Rastislav,Gazzah Anas,Varga Andrea,Postel-Vinay Sophie,Loriot Yohann,Even Caroline,Breuskin Ingrid,Auger Nathalie,Job Bastien,De Baere Thierry,Deschamps Frederic,Vielh Philippe,Scoazec Jean-Yves,Lazar Vladimir,Richon Catherine,Ribrag Vincent,Deutsch Eric,Angevin Eric,Vassal Gilles,Eggermont Alexander,André Fabrice,Soria Jean-Charles

Funder

Fondation Gustave Roussy

MMO

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 531 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-Generation Sequencing Trends among Adult Patients with Select Advanced Tumor Types;The Journal of Molecular Diagnostics;2024-02

2. Data complexity in oncology;Die Onkologie;2024-01-17

3. Molekulare Tumorboards;Forum;2024-01-12

4. Pragmatic Nationwide Master Observational Trial Based on Genomic Alterations in Advanced Solid Tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II Study Protocol KCSG AL-22-09;2024-01-09

5. Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience;Cancers;2024-01-09